Published in Neuropharmacology on October 14, 2017
Chronic catheterization of the spinal subarachnoid space. Physiol Behav (1976) 6.16
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol (1993) 3.63
Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J (2001) 2.51
mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol (1998) 2.14
Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science (1995) 2.12
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature (1980) 2.08
Intracellular calibration of the fluorescent calcium indicator Fura-2. Cell Calcium (1990) 2.03
Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat Neurosci (2007) 1.99
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science (2013) 1.91
Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods (1996) 1.74
Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther (2005) 1.69
NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature (1997) 1.65
Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci (1993) 1.65
Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. J Neurosci (1996) 1.58
Opioid receptor-coupled second messenger systems. Life Sci (1991) 1.58
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40
Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J Neurosci (1996) 1.35
Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J Neurosci (1997) 1.33
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci (2005) 1.33
Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J Neurosci (1999) 1.32
Presynaptic NMDA receptors modulate glutamate release from primary sensory neurons in rat spinal cord dorsal horn. J Neurosci (2004) 1.30
Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology (2001) 1.28
Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci (2005) 1.27
Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A (1994) 1.25
Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. J Neurosci (1997) 1.24
Mechanisms of inward-rectifier K+ channel inhibition by tertiapin-Q. Biochemistry (1999) 1.22
The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg (2002) 1.22
Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci (1997) 1.21
Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J Neurosci (1997) 1.18
Multiple targets of μ-opioid receptor-mediated presynaptic inhibition at primary afferent Aδ- and C-fibers. J Neurosci (2011) 1.17
Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res (1984) 1.15
Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalization in the rat spinal cord. Neuroscience (2003) 1.15
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J Pharmacol Exp Ther (1989) 1.13
Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev (2012) 1.12
Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J Comp Neurol (2002) 1.12
Spinal opioid analgesia: how critical is the regulation of substance P signaling? J Neurosci (1999) 1.10
Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. J Neurosci (2006) 1.10
Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. J Neurosci (1994) 1.09
mu-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. J Neurosci (1995) 1.09
The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology (2011) 1.06
Long-term potentiation induced by theta frequency stimulation is regulated by a protein phosphatase-1-operated gate. J Neurosci (2000) 1.04
Why the Schild method is better than Schild realised. Trends Pharmacol Sci (2007) 1.03
Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines. J Neurosci (2014) 1.02
Spinal NK-1 receptor-expressing neurons and descending pathways support fentanyl-induced pain hypersensitivity in a rat model of postoperative pain. Eur J Neurosci (2009) 1.02
Electrophysiological characterization of N-methyl-D-aspartate receptors in rat dorsal root ganglia neurons. Pain (2004) 1.01
Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol (2006) 1.00
Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice. Eur J Pharmacol (2011) 0.99
Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience (2000) 0.98
Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem Res (1996) 0.97
Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology (2005) 0.95
NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. Cell Signal (2008) 0.95
Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol Pharmacol (1997) 0.95
Internalization of mu-opioid receptors in rat spinal cord slices. Neuroreport (1999) 0.95
Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P. Neuroscience (2008) 0.94
Expression of mRNAs for neurotrophin receptors in the dorsal root ganglion and spinal cord during development and following peripheral or central axotomy. Brain Res Mol Brain Res (1993) 0.93
Glutamate induces a depolarization of adult rat dorsal root ganglion neurons that is mediated predominantly by NMDA receptors. Neurosci Lett (1988) 0.93
Differential actions of PKA and PKC in the regulation of glutamate release by group III mGluRs in the entorhinal cortex. J Neurophysiol (2001) 0.92
Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol (1998) 0.92
Upregulation of substance P in low-threshold myelinated afferents is not required for tactile allodynia in the chronic constriction injury and spinal nerve ligation models. J Neurosci (2007) 0.92
Neurokinin release produced by capsaicin acting on the central terminals and axons of primary afferents: relationship with N-methyl-D-aspartate and GABA(B) receptors. Neuroscience (2003) 0.91
Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition. Neuropharmacology (2007) 0.91
Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides (1990) 0.90
Constitutively active μ-opioid receptors. Methods Enzymol (2010) 0.90
Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons. Neuroscience (2007) 0.90
Ca2+ channels as integrators of G protein-mediated signaling in neurons. Mol Pharmacol (2004) 0.90
NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol (1998) 0.90
The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol Life Sci (2010) 0.90
The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol Med (2013) 0.89
Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. Curr Drug Abuse Rev (2012) 0.89
Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain. J Physiol (2013) 0.89
NMDA receptors in primary afferents require phosphorylation by Src family kinases to induce substance P release in the rat spinal cord. Neuroscience (2010) 0.89
Substance P release and neurokinin 1 receptor activation in the rat spinal cord increase with the firing frequency of C-fibers. Neuroscience (2009) 0.88
Activation of spinal d1/d5 receptors induces late-phase LTP of C-fiber-evoked field potentials in rat spinal dorsal horn. J Neurophysiol (2005) 0.86
GABA(A) receptor facilitation of neurokinin release from primary afferent terminals in the rat spinal cord. Neuroscience (2005) 0.86
Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci (1992) 0.86
Expression of mRNAs encoding full-length and truncated TrkB receptors in rat dorsal root ganglia and spinal cord following peripheral inflammation. Neuroreport (1999) 0.85
Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity. Biochem Soc Trans (2009) 0.85
Effect of NMDA NR2B antagonist on neuropathic pain in two spinal cord injury models. Pain (2012) 0.85
Delta-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Res (1996) 0.84
Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization. Neuroscience (2009) 0.84
Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord. Br J Pharmacol (2003) 0.84
BDNF released during neuropathic pain potentiates NMDA receptors in primary afferent terminals. Eur J Neurosci (2014) 0.83
Mu-opioid and GABA(B) receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons. Neuroscience (1998) 0.83
Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors. Brain Res (2008) 0.82
Oxidation of protein tyrosine phosphatases as a pharmaceutical mechanism of action: a study using 4-hydroxy-3,3-dimethyl-2H-benzo[g]indole-2,5(3H)-dione. J Pharmacol Exp Ther (2004) 0.81
Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors. Eur J Neurosci (2010) 0.79
G protein-coupled inwardly rectifying potassium channels in dorsal root ganglion neurons. Acta Pharmacol Sin (2007) 0.79
Characterisation of N-methyl-D-aspartate receptor-specific [(3)H]Ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes. J Neurochem (2000) 0.79
Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors. Br J Pharmacol (1998) 0.79
Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity. J Neurosci (2016) 0.78
Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP. Epilepsia (2009) 0.78
Kappa-opioid receptor modulation of the release of substance P in the dorsal horn. Brain Res (1996) 0.78
Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus. Eur J Pharmacol (1997) 0.77
Latent sensitization: a model for stress-sensitive chronic pain. Curr Protoc Neurosci (2015) 0.77
Omega-conotoxins as experimental tools and therapeutics in pain management. Mar Drugs (2013) 0.76
Inhibition of N-methyl-D-aspartate- and kainic acid-induced neurotransmitter release by omega-conotoxin GVIA. Br J Pharmacol (1989) 0.76
Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord. Neuropharmacology (2017) 0.76